Market Overview:
The global marine biomedicine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for marine animal technology and marine plant technology products for drug discovery and health care applications. North America is expected to lead the global marine biomedicine market in terms of revenue, followed by Europe, Asia Pacific, Latin America, and Middle East & Africa.
Product Definition:
Marine biomedicine is the study of how marine organisms can be used to improve human health. This includes the use of marine organisms for drug discovery, diagnostics, and therapies. Marine biomedicine is an important field because it can help us find new ways to treat diseases and improve human health.
Marine Animal Technolog:
Marine animal technology is the use of organisms obtained from marine animals for medical research and applications. The most commonly used marine animals are fish, mollusks, crustaceans and echinoderms. The most important application of Marine Animal Technology is in pharmaceuticals which accounts for more than half of the global market revenue share followed by biologics production. Pharmaceuticals derived through MAT account for more than one-third of all new drugs approved by the U.
Marine Plant Technology:
Marine plant technology and its usage in marine biomedicine refers to the use of plants, algae, bacteria or other microorganisms obtained from the sea for medical purposes. Marine plants have been used as a source of bioactive compounds and natural medicines across many cultures and countries. The increasing demand for alternative therapies along with growing consumer awareness regarding medicinal herbs is expected to drive this market over the forecast period.
Application Insights:
The drug segment dominated the global marine biotechnology market in 2017. This is owing to the growing usage of marine derived drugs for the treatment of various diseases. For instance, Nootropyl (L-theanine) is used as a nootropic agent and has been studied for its potential use as a cognitive enhancer in humans. The drug was extracted from green tea bushes grown on plantations off the Pacific coast of Mexico and Chile.
Health care products are expected to witness lucrative growth over the forecast period due to rising advancements made in this sector through bio-engineering techniques using seaweed extracts or animal parts such as collagen or keratinocytes that have high therapeutic value and can be used alone or along with other ingredients for better results.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of fishing communities and strong support from government are some factors contributing to the growth of this regional market. In addition, increasing research funding for marine biotechnology is also expected to drive growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income, growing population, and improving healthcare infrastructure in emerging countries such as China and India. Furthermore, increased focus on disease prevention through lifestyle modification has resulted in an increase in demand for nutritional products which will further boost revenue generation over the next eight years (8H). ‘’The Asia Pacific Biotechnology Industry Conference & Trade Show (APBICTS) was held from 15th - 17th November 2018 at Singapore Expo Hall A1 booth No.
Growth Factors:
- Increasing research and development activities in marine biomedicine field by private and public organizations for the treatment of various diseases.
- Growing demand for novel drugs and therapies for the treatment of cancer, infectious diseases, and other chronic illnesses.
- Rising number of mergers and acquisitions among marine biotechnology companies to expand their product portfolios and market reach.
- Proliferation of new technologies such as CRISPR-Cas9 that are helping in the identification and development of novel marine-based therapeutics faster than ever before.
Scope Of The Report
Report Attributes
Report Details
Report Title
Marine Biomedicine Market Research Report
By Type
Marine Animal Technolog, Marine Plant Technology
By Application
Drug, Health Care Products
By Companies
Marinova, NEB, BiotechMarine, GlycoMar, Marine Biotech, Nofima, Sams, Aquapharm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
134
Number of Tables & Figures
94
Customization Available
Yes, the report can be customized as per your need.
Global Marine Biomedicine Market Report Segments:
The global Marine Biomedicine market is segmented on the basis of:
Types
Marine Animal Technolog, Marine Plant Technology
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drug, Health Care Products
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Marinova
- NEB
- BiotechMarine
- GlycoMar
- Marine Biotech
- Nofima
- Sams
- Aquapharm
Highlights of The Marine Biomedicine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Marine Animal Technolog
- Marine Plant Technology
- By Application:
- Drug
- Health Care Products
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Marine Biomedicine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Marine Biomedicine is the study of how marine organisms can be used to improve human health. Marine biotechnology can help develop new drugs and treatments for a variety of diseases, including cancer, heart disease, and infectious diseases.
Some of the major players in the marine biomedicine market are Marinova, NEB, BiotechMarine, GlycoMar, Marine Biotech, Nofima, Sams, Aquapharm.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Marine Biomedicine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Marine Biomedicine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Marine Biomedicine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Marine Biomedicine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Marine Biomedicine Market Size & Forecast, 2018-2028
4.5.1 Marine Biomedicine Market Size and Y-o-Y Growth
4.5.2 Marine Biomedicine Market Absolute $ Opportunity
Chapter 5 Global Marine Biomedicine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Marine Biomedicine Market Size Forecast by Type
5.2.1 Marine Animal Technolog
5.2.2 Marine Plant Technology
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Marine Biomedicine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Marine Biomedicine Market Size Forecast by Applications
6.2.1 Drug
6.2.2 Health Care Products
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Marine Biomedicine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Marine Biomedicine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Marine Biomedicine Analysis and Forecast
9.1 Introduction
9.2 North America Marine Biomedicine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Marine Biomedicine Market Size Forecast by Type
9.6.1 Marine Animal Technolog
9.6.2 Marine Plant Technology
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Marine Biomedicine Market Size Forecast by Applications
9.10.1 Drug
9.10.2 Health Care Products
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Marine Biomedicine Analysis and Forecast
10.1 Introduction
10.2 Europe Marine Biomedicine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Marine Biomedicine Market Size Forecast by Type
10.6.1 Marine Animal Technolog
10.6.2 Marine Plant Technology
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Marine Biomedicine Market Size Forecast by Applications
10.10.1 Drug
10.10.2 Health Care Products
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Marine Biomedicine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Marine Biomedicine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Marine Biomedicine Market Size Forecast by Type
11.6.1 Marine Animal Technolog
11.6.2 Marine Plant Technology
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Marine Biomedicine Market Size Forecast by Applications
11.10.1 Drug
11.10.2 Health Care Products
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Marine Biomedicine Analysis and Forecast
12.1 Introduction
12.2 Latin America Marine Biomedicine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Marine Biomedicine Market Size Forecast by Type
12.6.1 Marine Animal Technolog
12.6.2 Marine Plant Technology
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Marine Biomedicine Market Size Forecast by Applications
12.10.1 Drug
12.10.2 Health Care Products
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Marine Biomedicine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Marine Biomedicine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Marine Biomedicine Market Size Forecast by Type
13.6.1 Marine Animal Technolog
13.6.2 Marine Plant Technology
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Marine Biomedicine Market Size Forecast by Applications
13.10.1 Drug
13.10.2 Health Care Products
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Marine Biomedicine Market: Competitive Dashboard
14.2 Global Marine Biomedicine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Marinova
14.3.2 NEB
14.3.3 BiotechMarine
14.3.4 GlycoMar
14.3.5 Marine Biotech
14.3.6 Nofima
14.3.7 Sams
14.3.8 Aquapharm
